Yankaddy
Sales Banner.jpg

Sales

Get Ahead with Yankaddy®

Sales


The Yankaddy® average cost to initially fulfill a facility is much less than the $25,000-$40,000 cost to treat just one healthcare-associated infection.


The product

The Yankaddy® (patent pending) is a disposable holster designed to releasably retain the Yankauer suction instrument and prevent undesired movement of the Yankauer. It easily attaches to the Yankaddy® reusable bracket, that features an adjustable arm with a spring clamp, making it easy to attach to numerous places such as bedrails, counters, equipment, and IV poles so that it is always where it needs to be, when it needs to be there.



The benefit

Until now, there has not been a place to store the Yankauer suction instrument before and during its use in a medical procedure. The Yankaddy® offers a reliable place to store the Yankauer suction instrument thereby keeping the environment from becoming contaminated and spreading healthcare-associated infections. It was designed to be used with one hand, adding safety to patients and convenience to medical providers.


Get Ahead of the Game with Your Infection Control Plan

In October 2014, CMS began reducing Medicare payments for hospitals that rank in the worst performing quartile of subsection hospitals with respect to hospital-acquired conditions (HACs).

Don't Wait Until Your Facility Gets Cited and Fined For Not Having a Place To Store Your Yankauer

The new CMS policy involves healthcare-associated infections (HAIs), which are a common, expensive, and often preventable cause of inpatient morbidity and mortality. Approximately 2 million patients per year develop HAIs, or about 5% of acute hospital admissions. The last decade alone has seen an estimated 36% increase in HAIs (1). The estimated 100,000 deaths per year associated with HAIs rank this as the sixth leading cause of death in the United States (2). In a recent study capturing additional underlying expenses, the excess hospital cost of HAIs across the nation was estimated to be between 28-45 billion dollars annually (3).

The aim of the CMS hospital-acquired condition reimbursement policy is to drive changes in organizational structures that may facilitate process change including the development of care pathways and ultimately clinician behavior change. This is in contrast to other pay-for-performance initiatives where individuals are directly paid to consciously modify their behavior (4). 

 

References:

1.  Institute of Medicine. To Err is Human: Building A Safer Health System. Washington, DC: National Academy Press; 2000.

2.  Klevens RM, Edwards JR, Richards C, Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–166. [PMC free article]  [PubMed].

3.   Scott R., II Division of Healthcare Quality Promotion National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. 2009. [Accessed September 25, 2009]. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf.

4.   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881841/